What is the expected timeline for the completion of the acquisition by Sycamore Partners?

The transaction is expected to close in the fourth quarter of 2025, pending customary closing conditions and regulatory approvals.

How will going private affect Walgreens' operations and strategy?

Going private will allow Walgreens to focus on its turnaround strategy without public market pressures, potentially leading to significant restructuring and operational improvements.

What are the potential plans for Walgreens' VillageMD unit following the acquisition?

Walgreens is exploring all options to improve VillageMD's financial performance, including potential monetization transactions, and has formed a committee to consider various paths.

What is the total potential value of the acquisition, including debt and future payouts?

The total potential value of the acquisition could reach up to $23.7 billion when accounting for debt and future payouts.

3 sources·Business

Walgreens Boots Alliance to be Acquired by Sycamore Partners for $10 Billion

Walgreens Boots Alliance agrees to a $10 billion acquisition by Sycamore Partners, marking a significant shift towards privatization amid financial struggles.

33%

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).

Mostly Reliable

The underlying sources are generally reliable but sometimes include opinion, propaganda, or minor inaccuracies.

Balanced

The underlying sources are either a balanced mix of left and right or primarily centrist.

Its fortunes collapsed as drug margins fell and as consumers turned to cheaper rivals such as Amazon and Walmart to fill their prescriptions and purchase toiletries.
Walgreens to Be Acquired by Sycamore Partners for $10 Billion
Epoch Times·13d
Mixed Reliable
This source has a mixed track record—sometimes accurate but also prone to bias, sensationalism, or incomplete reporting.
·
Right
This outlet favors right-wing views.
Walgreens’ market capitalisation has collapsed by 90% since 2015 and is now valued at $9.3bn.
US owner of UK pharmacy chain Boots to be taken private in $10bn deal
The Guardian·13d
Reliable
This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
·
Leans Left
This outlet slightly leans left.
A buyout to take the drugstore chain private would give it more flexibility to make changes to improve its business without worrying about Wall Street's reaction.
Walgreens agrees to be acquired by private equity firm for almost $10 billion
NPR·13d
Reliable
This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
·
Center
This outlet is balanced or reflects centrist views.

Mar 7th, 2025, 6:49 AM ET

Summary

A summary of the key points of this story verified across multiple sources.

Walgreens Boots Alliance has agreed to be acquired by Sycamore Partners for approximately $10 billion, ending its 98-year run as a publicly traded company. This deal follows years of financial losses and declining market capitalization, significantly down from a peak of $100 billion. Shareholders may receive additional payments of up to $3 per share related to the sale of Walgreens' VillageMD primary care business. The company aims to improve operational flexibility to execute its turnaround strategies away from public market pressures as it navigates a challenging retail environment.

Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.

Walgreens Boots Alliance is being acquired by Sycamore Partners for $10 billion, a significant drop from its former $100 billion valuation as the company struggles to adapt in a changing retail landscape.
The buyout allows Walgreens to operate with greater flexibility away from public scrutiny, potentially aiding its turnaround efforts amidst challenges such as thinning margins and competition from e-commerce giants.
Investors may see additional compensation up to $3 per share based on the future monetization potential of Walgreens' VillageMD clinic business, showcasing its strategic shift in focus.

FAQs

A list of follow-up questions readers often ask about this story.